Meiling Wang

Title: Meiling Wang: Innovator in Monoclonal Antibodies and Telecommunications

Introduction

Meiling Wang is a prominent inventor based in Shanghai, China. She has made significant contributions to the fields of biotechnology and telecommunications. With a total of 4 patents, her work focuses on innovative solutions that address critical challenges in these industries.

Latest Patents

One of her latest patents is the "Anti-human LAG-3 monoclonal antibody and use thereof." This invention discloses an antibody targeting LAG-3, along with its preparation method and applications. The novel monoclonal antibody exhibits high specificity and affinity for LAG-3 antigens, demonstrating significant anti-tumor activity. Another notable patent is related to a "scheduling method and base station." This invention outlines a process where a target base station can proactively send an uplink grant to a terminal during a cell handover, thereby reducing uplink transmission latency.

Career Highlights

Meiling Wang has worked with leading companies in the technology sector, including Huawei Technologies Co., Limited and Katerra Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in both telecommunications and biotechnology.

Collaborations

Throughout her career, Meiling has collaborated with notable professionals, including Xiangzhen Kong and Lian Li. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Meiling Wang's contributions to the fields of biotechnology and telecommunications highlight her role as a leading inventor. Her innovative patents and collaborations reflect her commitment to advancing technology and improving lives through her work.